Shiraz E-Medical Journal

Published by: Neoscriber Demo Publisher

The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats

Naser Khalaji 1 , Ahad Zeinali 2 , Masomeh Purjabali 3 , Kia Bolurani 4 and Amin Abdollahazade Fard 1 , *
Authors Information
1 Department of Physiology, Urmia University of Medical Sciences, Urmia, IR Iran
2 Department of Medical Physics, Urmia University of Medical Sciences, Urmia, IR Iran
3 Pathology center, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, IR Iran
4 Faculty of Medicine, Urmia University of Medical Sciences, Urmia, IR Iran
Article information
  • Shiraz E-Medical Journal: April 2018, 19 (4); e60572
  • Published Online: March 11, 2018
  • Article Type: Research Article
  • Received: August 20, 2017
  • Revised: January 20, 2018
  • Accepted: February 10, 2018
  • DOI: 10.5812/semj.60572

To Cite: Khalaji N, Zeinali A, Purjabali M, Bolurani K, Abdollahazade Fard A. The Effect of Bioactive Component of Turmeric (curcumin) on Liver Complications - Induced by Compact Fluorescent Lamps (CFLs) in Rats, Shiraz E-Med J. 2018 ; 19(4):e60572. doi: 10.5812/semj.60572.

Copyright © 2018, Shiraz E-Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Sayre RM, Dowdy JC, Poh-Fitzpatrick M. Dermatological risk of indoor ultraviolet exposure from contemporary lighting sources. Photochem Photobiol. 2004;80:47-51. doi: 10.1562/2004-02-03-RA-074.1. [PubMed: 15339209].
  • 2. Lopez-Camarillo C, Ocampo EA, Casamichana ML, Perez-Plasencia C, Alvarez-Sanchez E, Marchat LA. Protein kinases and transcription factors activation in response to UV-radiation of skin: implications for carcinogenesis. Int J Mol Sci. 2012;13(1):142-72. doi: 10.3390/ijms13010142. [PubMed: 22312244].
  • 3. Nishimura N, Tohyama C, Satoh M, Nishimura H, Reeve VE. Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice. Immunology. 1999;97(1):77-83. [PubMed: 10447717].
  • 4. Klein RS, Sayre RM, Dowdy JC, Werth VP. The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. Autoimmun Rev. 2009;8(4):320-4. doi: 10.1016/j.autrev.2008.10.003. [PubMed: 18992852].
  • 5. Cole C, Forbes PD, Davies RE, Urbach F. Effect of indoor lighting on normal skin. Ann N Y Acad Sci. 1985;453:305-16. [PubMed: 3865590].
  • 6. Klein RS, Werth VP, Dowdy JC, Sayre RM. Analysis of compact fluorescent lights for use by patients with photosensitive conditions. Photochem Photobiol. 2009;85(4):1004-10. doi: 10.1111/j.1751-1097.2009.00540.x. [PubMed: 19320850].
  • 7. Yin Y, Li W, Son YO, Sun L, Lu J, Kim D, et al. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol Appl Pharmacol. 2013;269(2):89-99. doi: 10.1016/j.taap.2013.03.015. [PubMed: 23545178].
  • 8. Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature. 2000;403(6772):859-66. doi: 10.1038/35002510. [PubMed: 10706276].
  • 9. Tsai CF, Lu FJ, Hsu YW. Protective effects of Dunaliella salina - a carotenoids-rich alga - against ultraviolet B-induced corneal oxidative damage in mice. Mol Vis. 2012;18:1540-7. [PubMed: 22736944].
  • 10. Afaq F, Adhami VM, Mukhtar H. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat Res. 2005;571(1-2):153-73. doi: 10.1016/j.mrfmmm.2004.07.019. [PubMed: 15748645].
  • 11. Rajnochova Svobodova A, Galandakova A, Sianska J, Dolezal D, Ulrichova J, Vostalová J. Acute Exposure to Solar Simulated Ultraviolet Radiation Affects Oxidative Stress-Related Biomarkers in Skin, Liver and Blood of Hairless Mice. Biol Pharm Bull. 2011;34(4):471-9. doi: 10.1248/bpb.34.471.
  • 12. Meeran SM, Singh T, Nagy TR, Katiyar SK. High-fat diet exacerbates inflammation and cell survival signals in the skin of ultraviolet B-irradiated C57BL/6 mice. Toxico Appl Pharmacol. 2009;241(3):303-10. doi: 10.1016/j.taap.2009.09.003.
  • 13. Bogdanos DP, Gao B, Gershwin ME. Liver immunology. Comprehens Physiol. 2013;3(2):567-98.
  • 14. Hassan K, Bhalla V, El Regal ME, A-Kader HH. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol. 2014;20(34):12082.
  • 15. Kim KH, Park HM, Shon JC, Lee MY, Liu KH, Kim JK, et al. Mass Spectrometry-Based Metabolite Profiling in the Mouse Liver following Exposure to Ultraviolet B Radiation. PLoS ONE. 2014;9(10). e109479. doi: 10.1371/journal.pone.0109479.
  • 16. Joe B, Vijaykumar M, Lokesh BR. Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action. Crit Rev Food Sci Nutr. 2004;44(2):97-111. doi: 10.1080/10408690490424702.
  • 17. Zhou H, S. Beevers C, Huang S. The Targets of Curcumin. Curr Drug Targets. 2011;12(3):332-47. doi: 10.2174/138945011794815356.
  • 18. Wu A, Ying Z, Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol. 2006;197(2):309-17. doi: 10.1016/j.expneurol.2005.09.004.
  • 19. Wang R, Li Y, Li Y, Xu Y, Wu H, Li XJ. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 2008;1210:84-91. doi: 10.1016/j.brainres.2008.01.104.
  • 20. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014:186864. doi: 10.1155/2014/186864. [PubMed: 24877064].
  • 21. Cameron DW, Hann HW, Wan S, Myers RE, Hann RS, Xing J, et al. Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients. PLoS ONE. 2012;7(10). e47687. doi: 10.1371/journal.pone.0047687.
  • 22. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367-84. doi: 10.1053/gast.2002.36061.
  • 23. Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H. Low serum amylase in association with metabolic syndrome and diabetes: A community-based study. Cardiovasc Diabetol. 2011;10(1):34. doi: 10.1186/1475-2840-10-34.
  • 24. Gultekin FA, Bakkal BH, Guven B, Tasdoven I, Bektas S, Can M, et al. Effects of ozone oxidative preconditioning on radiation-induced organ damage in rats. J Radiat Res. 2012;54(1):36-44. doi: 10.1093/jrr/rrs073.
  • 25. Yun SS, Kim SP, Kang MY, Nam SH. Inhibitory effect of curcumin on liver injury in a murine model of endotoxemic shock. Biotechnol Lett. 2009;32(2):209-14. doi: 10.1007/s10529-009-0153-8.
  • 26. Ilbey YO, Ozbek E, Cekmen M, Simsek A, Otunctemur A, Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Human Reprod. 2009;24(7):1717-25. doi: 10.1093/humrep/dep058.
  • 27. Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S. Nanotechnology-Applied Curcumin for Different Diseases Therapy. BioMed Res Int. 2014;2014:1-23. doi: 10.1155/2014/394264.
  • 28. Goldberg IJ, Eckel RH, McPherson R. Triglycerides and Heart Disease: Still a Hypothesis?. Arteriosclerosis Thrombosis Vasc Biol. 2011;31(8):1716-25. doi: 10.1161/atvbaha.111.226100.
  • 29. Wang HH, Portincasa P, de Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, et al. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest. 2013;43(4):413-26. doi: 10.1111/eci.12058.
  • 30. Harber LC, Fleischer AS, Baer RL. Erythropoietic Protoporphyria and Photohemolysis. JAMA. 1964;189(3). doi: 10.1001/jama.1964.03070030013004.
  • 31. Hollaender A. Effects of Ultraviolet Radiation. Annual Rev Physiol. 1946;8(1):1-16. doi: 10.1146/
  • 32. Trovato FM, Catalano D, Musumeci G, Trovato GM. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics. EPMA J. 2014;5(1). doi: 10.1186/1878-5085-5-21.
  • 33. Marino L. Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol. 2015;21(39):11053. doi: 10.3748/wjg.v21.i39.11053.
  • 34. Bobe G, Young JW, Beitz DC. Invited Review: Pathology, Etiology, Prevention, and Treatment of Fatty Liver in Dairy Cows. J Dairy Sci. 2004;87(10):3105-24. doi: 10.3168/jds.S0022-0302(04)73446-3.
  • 35. Jr TMD. Alcohol-induced steatosis in liver cells. World J Gastroenterol. 2007;13(37):4974. doi: 10.3748/wjg.v13.i37.4974.
  • 36. Okushin K, Takahashi Y, Yamamichi N, Shimamoto T, Enooku K, Fujinaga H, et al. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. BMC Gastroenterol. 2015;15(1). doi: 10.1186/s12876-015-0247-9.
  • 37. Negro F. Hepatitis C Virus-Induced Steatosis: An Overview. Digest Dis. 2010;28(1):294-9. doi: 10.1159/000282105.
  • 38. Lazo M, Clark J. The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective. Seminars Liver Dis. 2008;28(4):339-50. doi: 10.1055/s-0028-1091978.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments